As its immunology work draws attention, Sanofi also pushes forward in rare disease Company plans to seek approval for another Gaucher disease drug

https://www.statnews.com/2026/02/02/sanofi-venglustat-gaucher-rare-disease-neurological-symptoms/ By Andrew JosephFeb. 2, 2026 Europe Correspondent